問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Medical University Hospital (在職)

Division of Endocrinology

更新時間:2023-09-19

黃千玲Huang, Chen-Ling
  • Principal Investigator
  • Clinical Trial Experience (year) 17 years 9 個月

篩選

List

14Cases

2011-07-01 - 2013-12-31

Phase III

A prospective, randomized, double-blind trial comparing the long-acting basal insulin analogue LY2963016 and Lantus® in adult patients with type 2 diabetes
  • Condition/Disease

    Type 2 diabetes

  • Test Drug

    LY2963016

Participate Sites
8Sites

Terminated8Sites

2017-08-01 - 2019-01-31

Phase III

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination with Insulin Glargine or Insulin Degludec in Adults with Type 2 Diabetes PRONTO-T2D
  • Condition/Disease

    Type 2 Diabetes

  • Test Drug

    LY900014

Participate Sites
5Sites

Terminated5Sites

2012-01-01 - 2013-09-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Terminated8Sites

2011-07-01 - 2013-09-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

1 2